IDEXX Laboratories Q2 2025 Earnings Call: Strong Revenue and EPS Growth Amid Challenges

IDEXX Laboratories Inc reported an 11% increase in revenue and a 17% growth in earnings per share on a comparable basis for Q2 2025. The company achieved a record quarter for premium instrument placements and increased its full-year revenue outlook by $90 million. However, CAG Diagnostic recurring revenue growth was constrained by macroeconomic and sector headwinds, and global Rapid assay revenues declined 3% organically.

IDEXX Laboratories Inc (IDXX) reported robust financial performance for the second quarter of 2025, with an 11% increase in revenue and a 17% growth in earnings per share (EPS) on a comparable basis. The company's strong performance was driven by a record quarter for premium instrument placements, including nearly 2,400 IDEXX inVue DX instruments [1].

The company's full-year revenue outlook was also increased by $90 million, now ranging from $4.25 billion to $4.29 billion [1]. This reflects the strong Q2 performance and favorable foreign exchange impacts. Operating profit grew by 14% on a comparable basis, benefiting from solid revenue growth and operating margin gains [1].

However, IDEXX faced challenges in certain areas. CAG Diagnostic recurring revenue growth was constrained by macroeconomic and sector headwinds, leading to a 2.5% decline in US same-store clinical visit growth levels [1]. Global Rapid assay revenues declined 3% organically in Q2, impacted by customers shifting pancreatic lipase testing to the Catalyst instrument platform [1].

Despite these challenges, IDEXX's stock gained 9.2% in the pre-market trading session following the earnings announcement [2]. The company's innovation-driven strategy continues to deliver solid global growth, with a focus on expanding its portfolio and maintaining customer loyalty.

References:

[1] https://www.gurufocus.com/news/3033685/idexx-laboratories-inc-idxx-q2-2025-earnings-call-highlights-strong-revenue-and-eps-growth-amid-macroeconomic-challenges

[2] https://finance.yahoo.com/news/idexx-stock-q2-earnings-revenue-135500687.html